EUVIMEDEUVIMED entdecken
Systematische Übersicht

Treatment Discontinuation, Interruption, and Rechallenge With Enfortumab Vedotin Plus Pembrolizumab in a Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review

Misbah Kassam, Faraz Sharif

Cureus · 19.11.2026

DOI: 10.7759/cureus.119928 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Cureus, erschienen am 19.11.2026. Verfasst von Misbah Kassam und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kassam, M., & Sharif, F. (2026). Treatment Discontinuation, Interruption, and Rechallenge With Enfortumab Vedotin Plus Pembrolizumab in a Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review. Cureus. https://doi.org/10.7759/cureus.119928

Vancouver

Kassam M, Sharif F. Treatment Discontinuation, Interruption, and Rechallenge With Enfortumab Vedotin Plus Pembrolizumab in a Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review. Cureus. 2026. doi:10.7759/cureus.119928

BibTeX
@article{Kassam2026,
  author = {Kassam, Misbah and Sharif, Faraz},
  title = {Treatment Discontinuation, Interruption, and Rechallenge With Enfortumab Vedotin Plus Pembrolizumab in a Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Review},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119928}
}
Kostenlos starten →